Myotonic dystrophy (DM) is a triplet-repeat expansion disease, one of a group that includes Huntington's disease, Fragile X syndrome and Friedreich's ataxia 1,2 . The common form, DM1, is caused by a CTGrepeat expansion (CTG exp ) in the 3′ untranslated region (UTR) of the myotonic dystrophy protein kinase (DMPK) gene, leading to myotonia, muscle degeneration, reduced heart function, ocular cataracts and nervous system dysfunction 3 . RNA containing CUG repeats (CUG exp RNA) accumulates in nuclear foci 4, 5 . Based on its autosomal dominant inheritance, a leading hypothesis for the cause of DM1 is that CUG exp RNA is toxic. Mice engineered to express CUG exp RNA show many symptoms of myotonic dystrophy 6, 7 . In addition to altering RNA splicing (see below), CUG exp RNA has been proposed to disrupt a wide variety of cellular processes through several mechanisms, including "leaching" of transcription factors 8 , being processed into small RNAs that trigger inappropriate gene silencing 9 or activating PKC-dependent signaling pathways 10 . Among these, the contribution of splicing perturbations is most clear given the physiological relevance of several splicing alterations that occur when CUG exp RNA is expressed 5, 7, 11 . For example, aberrant splicing of transcripts from the chloride channel gene Clcn1 is responsible for the myotonia in skeletal muscle [12] [13] [14] [15] , and aberrant splicing of insulin receptor transcripts is associated with insulin resistance 16 .
Myotonic dystrophy (DM) is a triplet-repeat expansion disease, one of a group that includes Huntington's disease, Fragile X syndrome and Friedreich's ataxia 1, 2 . The common form, DM1, is caused by a CTGrepeat expansion (CTG exp ) in the 3′ untranslated region (UTR) of the myotonic dystrophy protein kinase (DMPK) gene, leading to myotonia, muscle degeneration, reduced heart function, ocular cataracts and nervous system dysfunction 3 . RNA containing CUG repeats (CUG exp RNA) accumulates in nuclear foci 4, 5 . Based on its autosomal dominant inheritance, a leading hypothesis for the cause of DM1 is that CUG exp RNA is toxic. Mice engineered to express CUG exp RNA show many symptoms of myotonic dystrophy 6, 7 . In addition to altering RNA splicing (see below), CUG exp RNA has been proposed to disrupt a wide variety of cellular processes through several mechanisms, including "leaching" of transcription factors 8 , being processed into small RNAs that trigger inappropriate gene silencing 9 or activating PKC-dependent signaling pathways 10 . Among these, the contribution of splicing perturbations is most clear given the physiological relevance of several splicing alterations that occur when CUG exp RNA is expressed 5, 7, 11 . For example, aberrant splicing of transcripts from the chloride channel gene Clcn1 is responsible for the myotonia in skeletal muscle [12] [13] [14] [15] , and aberrant splicing of insulin receptor transcripts is associated with insulin resistance 16 .
Among proteins that bind CUG exp RNA are homologs of Drosophila melanogaster muscleblind (muscleblind-like proteins Mbnl1-3) 17, 18 . Mbnl proteins contain four CCCH-type zinc fingers that recognize a YGCY motif repeated within the CUG repeat (CUGCUG) and can function in splicing regulation [19] [20] [21] . CUG repeats can form long double-stranded RNA structures in vitro 22 ; however, crystal structures of Mbnl1 zinc fingers in complex with RNA indicate that the WatsonCrick faces of the binding-site 5′-GC-3′ dinucleotide residues are buried in the protein and unavailable for duplex formation 20 . The colocalization of CUG exp RNA and Mbnl1 in nuclear foci suggests a place where sequestration occurs 4, 11, 17 .
Beside Mbnl1, the altered function of splicing factors CUGBP1 and hnRNP H have been proposed to serve a role in DM1 pathogenesis [23] [24] [25] [26] . To determine the role of Mbnl1, a homozygous Mbnl1 mutant mouse (Mbnl1 ∆E3/∆E3 ) was created 27 . Like mice expressing CUG exp RNA, mice deficient in Mbnl1 show characteristics of myotonic dystrophy including aberrant splicing 11, 19, 27 . Some but not all of the DM-like symptoms and aberrant splicing of six exons are rescued by adeno-associated virus (AAV)-mediated expression of Mbnl1 in CUG exp RNA-expressing mice 28 , leaving open the possibility that CUG exp RNA has other mechanisms of action. In addition, the broader impact on splicing of the loss or sequestration of Mbnl1 is unknown beyond the few genes tested so far.
To determine the extent to which the loss of Mbnl1 explains the splicing and gene-expression defects caused by CUG exp RNA, we compared mRNA in skeletal muscle of HSA LR mice 7 expressing CUG exp RNA to those in Mbnl1 ∆E3/∆E3 mice 27 using splicing-sensitive microarrays 29, 30 . We found that global splicing perturbations were remarkably congruent in these mice and identified more than 200 splicing events altered upon loss of Mbnl1. Testing of human exons orthologous to these new mouse Mbnl1-dependent exons suggests that humans with DM1 suffer many of the same mis-splicing events, identifying new potential splicing markers for the human disease. Mbnl1 RNA binding sequences 1 8 8 VOLUME 17 NUMBER 2 FEBRUARY 2010 nature structural & molecular biology a r t i c l e s were greatly enriched near the affected exons, suggesting that CUG exp RNA affects splicing primarily through Mbnl1. In contrast to splicing, many changes in mRNA levels are found in CUG exp RNA-expressing muscle but not in the Mbnl1 mutant, indicating a distinct second defect caused by CTG exp DNA. This defect seems unusually focused on genes expressing extracellular matrix (ECM) components and their regulators, some of which are known to have roles in other forms of muscular dystrophy and connective tissue diseases.
RESULTS
Splicing perturbations in muscle of HSA LR and Mbnl1 E3/E3 mice If Mbnl1 sequestration is the main cause of gene-expression perturbation in DM1, then transcripts from muscle genetically lacking Mbnl1 should appear broadly similar to those expressing CUG exp RNA. The extent of this similarity should provide a strong quantitative estimate of the extent to which the Mbnl1 sequestration hypothesis can explain the disease. To test this directly, RNA was extracted from the quadriceps muscles of age-matched males either carrying the HSA LR transgene expressing CUG exp RNA (HSA LR ) 7 , homozygous for the Mbnl1 knockout allele (Mbnl1 ∆E3/∆E3 ) 27 or homozygous wild-type Mbnl1 in the same (FBV) background, and analyzed on splicing-sensitive microarrays as described previously 29, 30 . Experience with this method indicates that differences in the log 2 of the ratio of exon skipping to inclusion (the skip/include ratio Fig. 1 ) between two samples ( Fig. 1a, sepscore; see Online Methods) with absolute value >0.3 can be validated by RT-PCR about 85% of the time 29, 30 . We observed 246 events in Mbnl1 ∆E3/∆E3 mice and 221 events in HSA LR mice that exceeded this score, distributed among different splicing modes (alternative cassette exons, alternative 5′ or 3′ splice sites, and mutually exclusive cassette exons; Fig. 1b and Supplementary Table 1 ). Even at this relatively crude level of analysis, nearly 80% of splicing events altered in HSA LR mice were also altered in Mbnl1 ∆E3/∆E3 mice. About half showed increased exon skipping after loss of Mbnl1, and half showed decreased skipping, indicating formally that Mbnl1 contributes to both activation and repression of splicing.
To evaluate whether the two disease models share quantitatively similar changes in splicing, we compared the sepscores for each splicing event altered (with |sepscore| ≥ 0.3) in both models. The R 2 value for this comparison was 0.84, suggesting that Mbnl1 loss of function explains more than 80% of the splicing phenotype caused by CUG exp RNA expression (Fig. 1c) . We used RT-PCR to validate a subset of the alternative cassette exons, as shown for a 123-nucleotide cassette exon repressed by Mbnl1 in the Nfix gene (encoding NF-I/X CAAT box-binding transcription factor, Fig. 1d ; see Online Methods). The 93-nucleotide exon of the Tlk gene represents the contribution of Mbnl1 to splicing activation, as skipping is increased in the mutants (Fig. 1d) . Of 33 other events tested, all but 1 behaved as expected from the arrays (FDR = 0.03, Supplementary Fig. 1 and Supplementary Table 1) . Of these, 28 are affected in both HSA LR and Mbnl1 ∆E3/∆E3 mice ( Fig. 1d;  Supplementary Fig. 1a) ; 4 appear affected only in Mbnl1 ∆E3/∆E3 (such as Ndrg2, Fig. 1e; Supplementary Fig. 1b) ; and 1 appears affected only in HSA LR ( Fig. 1f; Supplementary Fig. 1c ). The concordance observed by arrays (Fig. 1c) was confirmed by RT-PCR reactions quantified on an Agilent Bioanalyzer (R 2 = 0.88, Supplementary Fig. 1d) .
We found four splicing events affected in Mbnl1 ∆E3/∆E3 but not in HSA LR mice ( Fig. 1e and Supplementary Fig. 1b) . These might compete effectively for Mbnl1 against CUG exp RNA and thus may not be inhibited except at levels higher than those achieved by this transgene. We found only one event affected specifically in HSA LR mice (Fig. 1f) , suggesting that CUG exp RNA transgene expression can cause splicing defects by mechanisms other than simple loss of Mbnl1. Possibly the regulation of this exon is the responsibility of other factors that function in the Mbnl1 knockout mouse but not in HSA LR , such as Mbnl2, which is also sequestered by CUG exp RNA 31, 32 , or CUGBP1, whose activity is altered in CUG exp RNA-expressing cells 24 ; or perhaps the regulation is controlled by some other indirect or combinatorial mechanism (see below). Given that Mbnl2 is sequestered by CUG exp RNA 31, 32 , our results also indicate that Mbnl2 is largely unable to compensate for the loss of Mbnl1 in muscle: otherwise, we would have found many more splicing events perturbed in the HSA LR but not in the Mbnl1 ∆E3/∆E3 mouse. We conclude that the vast majority of splicing dysregulation in the CUG exp RNA-expressing muscle is due to catastrophic loss of Mbnl1 splicing-factor activity.
Sequence signatures of Mbnl1-regulated exons in muscle
To identify motifs associated with Mbnl1-regulated exons, we used Improbizer, which identifies sequence motifs present in a set of sequences . We quantified the RT-PCR products from three individual mice using the Bioanalyzer and calculated inclusion rates. We judged samples as being different from wild type if a t-test indicated that the sample was unlikely to be from the wild-type distribution with P < 0.05 (asterisks). 20 . We mapped the distribution of positions of CUGCY motifs to upstream and downstream intron regions ( Fig. 2c,d ). Introns upstream of Mbnl1-repressed exons, as well as part of the exon itself, were strongly enriched for CUGCY motifs, which often occur multiple times in individual pre-mRNAs. In contrast, the corresponding region of Mbnl1-activated exons was not enriched (Fig. 2c) . In the intron downstream of affected exons, both Mbnl1-repressed and Mbnl1-activated exons showed slight but marked enrichment in CUGCY elements above the background exons (Fig. 2d) . Enrichment for CUGBP1 or hnRNP H motifs was not observed (Supplementary Fig. 2 ). This pattern supports the argument that the splicing defects are primarily due to loss of Mbnl1 and suggests that regulation by Mbnl1 often involves its direct binding to regions near the exons it regulates.
To confirm the function of YGCY motifs in newly identified exons, we cloned the Mbnl1-activated exon from the Vldlr gene and the Mbnl1-repressed exon from the Nfix gene, each with their native flanking intron sequences, into a splicing reporter plasmid. We then mutated copies of the motif in each and tested them in mouse embryo fibroblasts lacking Mbnl1 (derived from the Mbnl1 ∆E3/∆E3 mouse), along with a construct expressing an Mbnl1-GFP fusion protein or GFP alone (Fig. 3a,b) . Splicing activation is promoted by the Mbnl1-GFP fusion protein for the wild-type but not the mutant Vldlr splicing reporter, indicating that the motif downstream of the exon is important for Mbnl1-mediated splicing activation (Fig. 3a) . Splicing repression is promoted by the Mbnl1-GFP fusion protein for the wild-type Nfix reporter and is only partly compromised by the alteration of four copies of the motif in the intron upstream of the exon. Complete loss of repression is achieved once three additional motif copies in the exon itself are altered (Fig. 3b) . These results confirm by reconstruction that newly identified exons depend on Mbnl1 for their correct splicing, and furthermore show that regulation is mediated by sequence motifs enriched in Mbnl1-regulated exons.
Mis-splicing events found in mouse are observed in human DM1
A handful of splicing defects are known in humans with DM1 (ref. 11). To determine whether humans with DM1 share newly identified splicing changes with the mouse DM1 models, we aligned affected mouse exons to the human genome and found 49 that are conserved and orthologous to Mbnl1-dependent mouse exons, 39 of which show strong evidence of alternative splicing in humans, according to the Alt Events track on the University of California, Santa Cruz Genome Browser 35 . We tested six for perturbation of splicing in people with DM1. The splicing of three genes (NFIX, SMYD1 and SPAG9) was perturbed in all three DM1-affected individuals tested, as compared to an unaffected human control, whereas for three others (GNAS, MTDH and PPP2R5C) splicing was clearly affected only in one or two of the three affected individuals (Fig. 4) . To rigorously determine the value of such changes in monitoring human DM1, more DM1-affected and unaffected individuals would need to be tested. Nonetheless, these and other 11 splicing changes indicate that Mbnl1-dependent events observed in the mouse are also observed in human DM1. Thus, exons affected in the mouse models 
Many changes in HSA LR mice are not explained by loss of Mbnl1
Besides influencing splicing, loss of Mbnl1 could lead to transcript-level changes, either directly, through nonsense-mediated decay caused by aberrant splicing (AS-NMD) 36 or altered mRNA stability, or indirectly, through mis-splicing of transcription-factor or splicing-factor mRNAs, all of which could combine to alter the transcriptome 37 . If Mbnl1 sequestration is the only mechanism by which CTG exp DNA alters gene expression, these myriad effects should be highly similar in both mouse models. To test this, we compared gene-expression changes in HSA LR mice to those in Mbnl1 ∆E3/∆E3 mice using the array probe intensities for all the constitutive (always-included) exons in each gene (see Online Methods). After filtering out genes with probes affected by cross-hybridization to the massive amounts of CUG exp RNA in the HSA LR mouse samples (see Online Methods), we identified 148 genes whose muscle transcript levels were significantly altered in HSA LR mice and 110 in the Mbnl1 ∆E3/∆E3 mice (≥1.5-fold change; q < 0.05 cutoff, Fig. 5a ). Of the 148 changes observed in HSA LR mice, 102 (69%) also appeared in Mbnl1 ∆E3/∆E3 mice, suggesting that, as for splicing, the underlying reason for those expression changes is loss of Mbnl1, either directly or indirectly through other factors. The 46 genes (31%) that change only in HSA LR mice indicate that CTG exp DNA imposes a second layer of dysregulation not shared by mice lacking Mbnl1. Overall, Mbnl1 loss explains a little more than half of the transcript-level variance between wild-type and HSA LR mice ( Fig. 5b ; R 2 = 0.57). We named the larger class of genes whose mRNA levels are altered in both models primarily because of loss of Mbnl1 "class I" genes, and those altered only in the HSA LR but not Mbnl1 ∆E3/∆E3 mice "class II" genes. In a more complex study using a very different array platform 37 , similar gene classes were identified that contained different genes (see Discussion). To validate the transcript-level changes, we used quantitative RT-PCR (qPCR, Fig. 5c and Supplementary Table 3) . Among the changes observed only in the HSA LR mice, more genes are downregulated than upregulated (Fig. 5c) . There is good agreement with the microarray data; however, the magnitude of the change detected is larger by qPCR, likely because of the smaller dynamic range of arrays. Because the class II changes do not occur in the Mbnl1 ∆E3/∆E3 mouse (at least by 12-14 weeks of age), they are unlikely to be a simple consequence of a loss of Mbnl1. However, the HSA LR mouse also suffers a loss of Mbnl1 function 28 , and it remains possible that Mbnl1 loss is necessary but not sufficient to produce the class II changes. We conclude that a substantial number of transcript-level changes occur in the HSA LR mouse that do not occur in the Mbnl1 ∆E3/∆E3 mouse.
To capture class II gene functions, we relaxed the array-measured fold change cutoff from 1.5-to 1.3-fold, since qPCR indicated that fold change is underestimated in this data. Because the filtering of cross-hybridizing CUG exp RNA in the samples is incomplete, some genes will artificially appear to be upregulated in the HSA LR mouse but not in the Mbnl1 ∆E3/∆E3 mouse. We avoided such genes by only considering those that were significantly downregulated in the HSA LR mouse relative to wild type (q < 0.05). To ensure that the genes on the list were specific to CTG exp effects, we required that their q values (FDRs) in both the HSA LR versus wild-type and the HSA LR versus Table 4 ).
Distinct impacts of CUG exp imposed through different sets of genes
Using the splicing changes and the class I and class II gene-expression change lists, we searched for functionally related gene classes that might provide insight into the disease. We performed a Gene Ontology (GO) analysis 38 using the background set of all genes expressed in the experiment (~6,000 genes of the ~10,000 on the array). Splicing changes were not significantly enriched (q ≥ 0.05) in any GO category (data not shown), suggesting that Mbnl1-regulated exons are distributed in several broad functional classes of genes. The category of class I genes, for which changes in expression presumably arise as an indirect consequence of the loss of Mbnl1 in splicing, is enriched for genes encoding insulin and insulin-like growth factor signaling and glucose metabolism (Supplementary Table 5 ), suggesting that loss of Mbnl1 has strong but specific effect on glucose metabolism in muscle cells. Other musclecell terms such as contractile fiber and muscle development are also strongly associated with this gene set. Class II genes are very significantly enriched for those encoding or regulating components of the ECM (q < 0.001), with one-fifth of the genes (18/93) carrying this functional label (Supplementary Table 6 ). Fifteen are orthologous to human genes involved in other forms of muscular dystrophy, myopathies and several connective tissue diseases, or their deletion in mouse creates a similar defect ( Table 1,  Supplementary Table 7) . We conclude that the coordinated dysregulation of a large set of genes associated with ECM function is caused by a second effect of CTG exp DNA that is not explained by the simple loss of Mbnl1.
We analyzed the sequences associated with the 5′ and 3′ UTRs of the downregulated class II genes. Using the frequency of 7-mer sequence words, we find that sequences containing the Mbnl1 motif (YGCY) are enriched in the UTRs of the 93 class II mRNAs. There is a substantial enrichment of GGUGCUA in the 3′ UTRs as well as enrichment of several related words in the 5′ UTRs (UGCCUGC, CCUGCCU, UGUGCCU; Supplementary Table 8) . Because of the extreme similarity between the RNA-binding domains of Mbnl1 and Mbnl2, it seems likely that the two proteins bind highly related RNA sequences 21, 39 . Because Mbnl2 is sequestered by CUG exp RNA 31, 32 , these results lead to the hypothesis that expression of class II genes might be altered through loss of Mbnl2 function mediated through binding to the UTRs of the mRNAs. The enrichment of Mbnl binding sites observed in the 93 class II mRNAs is also observed in the subgroup of class II genes that encode ECM components (Supplementary Table 8 ). Mbnl2 colocalizes with integrin α3 mRNA in the cytoplasm and promotes its expression at the cell surface 40 . Because integrins are ECM components, it is tempting to propose that Mbnl2 plays a general role in promoting correct localization, stability and translation of mRNAs encoding ECM proteins and their regulators.
DISCUSSION

Loss of Mbnl1 is the major cause of CUG exp RNA splicing toxicity
Our genome-wide test of the Mbnl1 sequestration hypothesis identified a large set of mouse muscle splicing events that depend on Mbnl1 and compared them to splicing changes caused by toxic CUG exp RNA. Strikingly, genetic loss of Mbnl1 accounts for about 80-90% of the altered splicing phenotype in the CUG exp RNA-expressing mice ( Fig. 1  and Supplementary Fig. 1 ). The extreme similarity of global splicing defects supports a sequestration model in which CUG exp RNA creates a catastrophic loss of Mbnl1 splicing function in DM1. This is confirmed by the presence of Mbnl1 binding motifs in and near exons whose splicing is compromised by loss of Mbnl1 (Figs. 2 and 3) . Our analysis was unable to identify enrichment of motifs for other splicing factors implicated in DM1 pathogenesis, such as CUGBP1 . 23,25) or hnRNP H (ref. 23) , and neither we (this study) nor previous work 25 studying the developing heart found strong coenrichment of CUGBP1 motifs with Mbnl1-dependent exons. We also found rare splicing changes specific to each model (Fig. 1) . Thus, although Mbnl1 loss is the major contributor to splicing defects in the HSA LR mouse, other factors also contribute in more subtle ways. A cascade of other perturbations due to Mbnl1 loss also occurs. These encompass changes in transcript level ( Fig. 5 ; see also ref. 37) . Fully 69% of the transcript-level changes observed in the Mbnl1 ∆E3/∆E3 mouse are also observed in the HSA LR mouse (class I genes). Many of these involve no altered splicing, but they could depend directly on Mbnl1 (if it has a role in mRNA stabilization) or could be altered through indirect effects resulting from the loss of splicing regulation for transcription or other RNA stability factors. The broad impact of Mbnl1 loss makes following the threads of each perturbation to the mechanistic source of each disease symptom a daunting prospect. Whether direct or indirect, perturbations that arise from loss of Mbnl1 are pervasive and complex and may explain the medical complexities of the human disease. The mouse models reveal defects parallel to those in humans with DM1 (Fig. 4) , suggesting that diagnostic tests for a wide spectrum of genes that depend on Mbnl1 function may presage DM1 onset or allow sensitive evaluation of therapies.
What causes perturbations not attributable to Mbnl1 loss?
A second class of gene-expression perturbations occurs in CUG exp RNA-expressing mice but not in mice lacking Mbnl1 (class II genes). A surprising fraction is associated with ECM function (Fig. 6 and  Supplementary Tables 6 and 7) . We propose that their dysregulation is due to loss of function of a second factor. The leading candidate for such a factor is Mbnl2, which like Mbnl1 is sequestered by CUG exp RNA 5,31,32,41 . The RNA-binding domains of Mbnl1 and Mbnl2 are nearly identical, and UTRs of class II genes are enriched in Mbnl RNA motifs (Supplementary Table 8) , supporting this hypothesis. A mouse Mbnl2 mutant has a relatively mild phenotype that includes muscle fibrosis; however, expression of residual Mbnl2 has not been strictly ruled out in this system 42 . The enrichment of ECM genes among the class II set ( Fig. 6 and Supplementary Tables 6 and 7) , combined with the finding that Mbnl2 colocalizes with integrin α3 mRNA and promotes localization of the integrin protein at focal adhesions 40 , makes it reasonable to postulate that Mbnl2 serves a general role in promoting correct expression of ECM molecules.
Tracing CUG exp RNA toxicity from gene to disease phenotype Loss of Mbnl1 through sequestration by CUG exp RNA contributes to changes in muscle morphology and excitability as indicated by studies with Mbnl1-deficient mice 27 . These include aberrant splicing of Clcn1, causing myotonia 14, 15, 43 ; mis-splicing of Camk2g, causing interference in excitation-contraction coupling 44 ; and alteration of Acvr2a expression, disturbing regulation of muscle growth 45 . A large number of new candidates associated with ion channels, cytoskeleton and myotubule composition, glucose metabolism and signal transduction may lead to additional defects ( Supplementary Tables 1 and 3) .
Despite this, loss of Mbnl1 does not produce the progressive muscle wasting observed in DM1. Previous work reported that transgenic mice with 960 CTG repeats in the Dmpk 3′ UTR display muscle loss not observed in Mbnl1 ∆E3/∆E3 mice 6, 27 . We found that CUG exp RNA but not genetic loss of Mbnl1 causes alteration of a broad set of ECM mRNAs (Fig. 6 ) that could worsen with age or increased repeat expansion, as observed in the human disease. Consistent with this, mutations in some of these same ECM genes cause muscular dystrophies or connective tissue diseases [46] [47] [48] (Table 1) . For example, defects in collagen I cause osteogenesis imperfecta with muscle weakness 49 , whereas mutations in Col6a1 are responsible for Ullrich congenital muscular dystrophy 50 . Col15a1 is involved in maintaining ECM structural integrity, and Col15a1-deficient mice show progressive muscle fiber degeneration 51 . Defects in elastin assembly also affect muscle strength and regeneration. Fibrillin-1 (FBN1) mutation causes Marfan syndrome with muscle involvement 52, 53 . Loss of fibulin-5 contributes to age-related muscular degeneration 54, 55 . Tenascin C interacts with integrin (integrin α7 mutations cause congenital muscular dystrophy), and Tnc-deficient mice show reduced muscle strength 56 . Unlike EpA960 transgenic mice 6 , HSA LR mice do not develop severe muscle weakness and wasting, so more extreme alterations in ECM gene expression may promote a more severe dystrophic phenotype. Together, these data overwhelmingly point to the idea that a loss of regulation of ECM function and the consequent effects on cell adhesion contribute to muscle defects in DM1 (Table 1 and Fig. 6 ).
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Accession codes. Microarray data for this study has been deposited in GEO under accession number GSE17986. 
ONLINE METhODS
Sample preparation and Affymetrix splicing microarray detection. We compared RNA samples from the quadriceps muscle of individual 12-to 14-week-old male mice from the Mbnl1 ∆E3/∆E3 , HSA LR and FVB inbred background lines (n = 4 for each group). To identify Mbnl1-dependent splicing events in heart (shown in Supplementary Table 2) , we compared RNA from quadriceps muscle and heart from Mbnl1 ∆E3/∆E3 mice and age-matched wild-type mice in the C57BL/6J background. We processed RNA samples for hybridization to Affymetrix "A-chip" oligonucleotide microarrays 29 according to the standards of the manufacturer.
Microarray data analysis.
We performed the analysis as described 29 with modifications indicated below. Preliminary analysis of data for the HSA LR mice indicated that probes with any 7-mer comprised of CTG repeats reported much higher intensities than others in the same gene, likely reflecting cross-hybridization driven by the large mass of CUG exp RNA in the sample. We corrected for this by ignoring any gene with more than four probes containing the three 7-mer permutations of (CTG) n : CTGCTGC, GCTGCTG or TGCTGCT.
The separation score (sepscore) method 29 is illustrated for the Nfix(123) exon in Figure 1a : when exon skipping (Skip) intensities are plotted against exon inclusion (Include) intensities, the wild-type samples appear on the left side of the graph whereas the Mbnl1 ∆E3/∆E3 and HSA LR samples appear in the lower right, indicating a shift from exon skipping in the wild-type to inclusion in the mutants. The equation for sepscore is:
For each replicate set (HSA LR , Mbnl1 ∆E3/∆E3 and wild type), we estimated the log 2 ratio of skipping to inclusion using robust least-squares analysis. We evaluated sepscore significance by permuting the assignments of data points to replicate sets, calculating the sepscore for the permuted data and estimating the likelihood that the observed data came from the permuted distribution. We estimated rates of overall gene expression according to probe sets that measure constitutive features. We identified genes that are differentially expressed between replicate sets using the SAM software 57 .
RT-PCR and Bioanalyzer analysis. We reverse transcribed total RNA to cDNA with Superscript III (Invitrogen) and oligo-dT using the manufacturer's protocol. Then we used ~50 ng cDNA as template for PCR with primers to regions spanning the test cassette exons (Supplementary Table 9 ). We carried out PCR for 25-35 cycles using the Platinum Taq polymerase (Invitrogen). To measure splicing, we separated 1 µl PCR products from above reaction on the Agilent Bioanalyzer, which then reported the size and concentrations of each splicingderived product.
Quantitative RT-PCR. We carried out quantitative RT-PCR in 30-µl reactions using Brilliant QRT-PCR Master Mix kits (SYBR-Green, Stratagene) on a Bio-Rad iCycler. We used GAPDH for normalization and the protocol of previous work 58 for calculating changes in threshold cycles.
Analysis of sequence motifs. We used Improbizer to search intronic sequences flanking each differentially-spliced exon. Background sequences were from alternative exons that were expressed but showed no changes in splicing.
(1) (1)
We searched for four copies of each motif during its search (maxOcc setting = 4). To map motifs, we searched in 40-base windows (offset by 5 bases) through the 150-base region immediately upstream and downstream of each alternative exon. We contrasted 55 Mbnl1-repressed exons (skipping lost in the mutant), 66 Mbnl1-induced exons (inclusion lost in the mutant) and 790 alternative exons expressed without splicing changes. We determined background motif frequencies by randomly sampling equivalent numbers of exons from the background 1,000 times per sequence window. We determined mean background counts and the 95% confidence interval through quartile analysis.
To identify sequence words associated with class II genes, we contrasted the sequences of the 5′ and 3′ UTRs to those of all genes expressed in the experiment. We determined the number of times each k-mer appeared in the selected sequences and in the background, for k = 5, k = 6 and k = 7. We used a public Perl module (StatisticsChisqIndep) for χ 2 evaluation of 2 × 2 contingency table data to determine the likelihood (p value) that the observed enrichment was due to chance. We applied a Bonferroni correction by multiplying the p value by the number of all possible k-mers (4 k ). This correction does not assume independence and ignores the fact that many k-mers appear only rarely in the genome. We considered k-mers to be significantly enriched in the test set relative to background if their false discovery rates were ≤ 0.1 (Supplementary Table 8 ).
Cloning, mutagenesis, cell culture and transfection. The human β-globin Dup33 minigene plasmid 59 (gift of D. Black) was used to create splicing reporters. The Vldlr(84) and Nfix(123) exons and associated intron sequences (~200 bp on each side) were amplified from mouse genomic DNA and inserted between the ApaI and BglII sites. Mutagenesis was performed using the QuikChange SiteDirected Mutagenesis Kit (Stratagene Corp.)
We immortalized mouse embryonic fibroblasts from Mbnl1 ∆E3/∆E3 (C57BL/6J background) by transfection with pOT, a plasmid expressing SV40 T-antigen 60 (gift of X.-D. Fu). We grew the cells in antibiotic-free DMEM with 15% (v/v) FBS. To test the function of Mbnl1 and the motifs, 0.5 µg wild-type or mutant minigenes and 1 µg of pEGFP-MBNL1 (ref. 28) or of the control plasmid producing only GFP (pEGFPC1) were co-transfected using Lipofectamine 2000 reagent (Invitrogen). We harvested RNA 24 h after transfection.
Detection of enrichment of functional gene classes. We evaluated Gene Ontology term enrichment using GoMiner 38 (Version 200904, April 2009; Application Build 246), relative to the set of all genes expressed in the experiment. Because we used Fisher′s exact test for scoring, enrichment of GO classes for which there are five or fewer genes must be considered tentative.
